230 related articles for article (PubMed ID: 11801364)
1. Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture.
Jeyarasasingam G; Tompkins L; Quik M
Neuroscience; 2002; 109(2):275-85. PubMed ID: 11801364
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic receptors and Parkinson's disease.
Quik M; Jeyarasasingam G
Eur J Pharmacol; 2000 Mar; 393(1-3):223-30. PubMed ID: 10771017
[TBL] [Abstract][Full Text] [Related]
5. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.
Wooltorton JR; Pidoplichko VI; Broide RS; Dani JA
J Neurosci; 2003 Apr; 23(8):3176-85. PubMed ID: 12716925
[TBL] [Abstract][Full Text] [Related]
6. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons.
Matsubayashi H; Inoue A; Amano T; Seki T; Nakata Y; Sasa M; Sakai N
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):1-7. PubMed ID: 15469877
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
[TBL] [Abstract][Full Text] [Related]
8. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
Kress GJ; Reynolds IJ
Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
[TBL] [Abstract][Full Text] [Related]
10. Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston JW
Neuroscience; 2000; 100(1):63-72. PubMed ID: 10996459
[TBL] [Abstract][Full Text] [Related]
11. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
Kawamata J; Suzuki S; Shimohama S
Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
[TBL] [Abstract][Full Text] [Related]
12. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
[TBL] [Abstract][Full Text] [Related]
14. Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage.
Quik M; Campos C; Parameswaran N; Langston JW; McIntosh JM; Yeluashvili M
J Mol Neurosci; 2010 Jan; 40(1-2):105-13. PubMed ID: 19685015
[TBL] [Abstract][Full Text] [Related]
15. Activation of α7-nAChRs protects SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death via ERK/p53 signaling pathway.
Xu S; Yang B; Tao T; Zhang J; Liu Y; Hu J; Fan Y; Zhang G
J Cell Physiol; 2019 Aug; 234(10):18480-18491. PubMed ID: 30912145
[TBL] [Abstract][Full Text] [Related]
16. Nicotine and nicotinic receptors; relevance to Parkinson's disease.
Quik M; Kulak JM
Neurotoxicology; 2002 Oct; 23(4-5):581-94. PubMed ID: 12428730
[TBL] [Abstract][Full Text] [Related]
17. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
18. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
Fu Y; Matta SG; Gao W; Sharp BM
Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles for nicotine in Parkinson's disease.
Quik M; Huang LZ; Parameswaran N; Bordia T; Campos C; Perez XA
Biochem Pharmacol; 2009 Oct; 78(7):677-85. PubMed ID: 19433069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]